Recce Pharmaceuticals Eulerpool Novinky

Recce Pharmaceuticals Novinky o akciích

Recce Pharmaceuticals je sledován mnoha novináři a investory po celém světě. Nejaktuálnější Recce Pharmaceuticals zprávy shromažďujeme zde.

• 10. prosince ·

  Yahoo
  Recce Pharmaceuticals Receives Approval from Indonesia’s Drug and Food Authority for Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
• 1. prosince ·

  Yahoo
  Investors in Recce Pharmaceuticals (ASX:RCE) have seen notable returns of 68% over the past five years
• 27. listopadu ·

  Yahoo
  Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
• 12. listopadu ·

  Yahoo
  Recce Pharmaceuticals Receives Ethics Approval in Indonesia to Commence Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
• 6. listopadu ·

  Yahoo
  Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 10. října ·

  Yahoo
  Recce Pharmaceuticals Announces Recruitment Passes Halfway in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 6. srpna ·

  Yahoo
  Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
• 10. července ·

  Yahoo
  Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
• 1. července ·

  Yahoo
  Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
• 25. června ·

  Yahoo
  Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections